Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension

Abstract EN

Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and stroke.

Essential hypertension (EH), a polygenic condition, has also been associated with increased risk of cardiovascular related disorders.

To investigate the role of the homocysteine (Hcy) metabolism pathway in hypertension we conducted a case-control association study of Hcy pathway gene variants in a cohort of Caucasian hypertensives and age- and sex-matched normotensives.

We genotyped two polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR C677T and MTHFR A1298C), one polymorphism in the methionine synthase reductase gene (MTRR A66G), and one polymorphism in the methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1 G1958A) and assessed their association with hypertension using chi-square analysis.

We also performed a multifactor dimensionality reduction (MDR) analysis to investigate any potential epistatic interactions among the four polymorphisms and EH.

None of the four polymorphisms was significantly associated with EH and although we found a moderate synergistic interaction between MTHFR A1298C and MTRR A66G, the association of the interaction model with EH was not statistically significant (P=0.2367).

Our findings therefore suggest no individual or interactive association between four prominent Hcy pathway markers and EH.